Review Article


Treatment modalities for peri-implantitis: A review of literature

,  

1 BDS, MSc., Lecturer, Department of Oral and Maxillofacial Surgery, College of Dentistry, University of Mosul, Mosul, Iraq

2 BDS, MSc, PhD, Assistant Professor, Department of Oral and Maxillofacial Surgery, College of Dentistry, University of Mosul, Mosul, Iraq

Address correspondence to:

Alyaa I Naser

Al. Falah Street, Mosul City,

Iraq

Message to Corresponding Author


Article ID: 100043D01AN2021

doi: 10.5348/100043D01AN2021RA

Access full text article on other devices

Access PDF of article on other devices

How to cite this article

Naser AI, Hamed RS. Treatment modalities for peri-implantitis: A review of literature. Edorium J Dent 2021;8:100043D01AN2021.

ABSTRACT


Introduction: Implant Dentistry was created to show reliable treatment approaches for restoring the oral cavity’s esthetic and function. However, while dental implants have a high long-term success rate, dental implants are exposed to mechanical or biological complications.

Objective: The therapeutic approaches will be addressed in this review, which is the main objective of this study.

Materials and Methods:

Data sources: The PubMed/MEDLINE, SCOPUS, and Web of Science databases were used to conduct the literature search from June to September 2021.

Study selection: Non-surgical and surgical peri-implantitis treatment modalities are the main themes of this study.

Result: Implant dentistry was created to show reliable treatment approaches for restoring the oral cavity’s esthetic and function. However, while dental implants have a high long-term success rate, dental implants are exposed to mechanical or biological complications.

Conclusion: Peri-implantitis appears to be a multifactorial disease including the patient’s host/microbe response, implant characteristics, soft tissue and the hard conditions surrounding the implant, and the dentist’s surgical and prosthetic part experience. Different treatment modalities are present today, all are used to treat peri-implantitis, such as surgery, laser therapy, and innovative treatments such as cold atmospheric pressure air plasma jet (CAPAJ), enamel matrix derivative, and PRF gel.

Keywords: Bone substitutes, Chlorhexidine, Dental implants, Peri-implantitis

INTRODUCTION


The revolution of implantology developed to display constant treatment modalities to restore the esthetic and function of the oral cavity. While the dental implant has a high success rate in the long period, the possibility of failure does exist. Documented classification based on pocket probing depth (PPD), clinical bleeding on probing (BOP), and radiographical evaluation of marginal bone-loss reduction. Two subtypes of peri-implant disease are prefaced by pathogenic bacteria [1] peri-implantitis and peri-implant mucositis [2],[3]. Peri-implant mucositis is a reversible inflammatory condition that affects the soft tissue surrounding dental implants, causing swelling, redness, and bleeding on probing [4]. Peri-implantitis is a prevalent condition that involves soft and hard tissue which results in loss of bony support and establishment of a peri-implant pocket around the osseointegrated implant [5]. There are three categories which classify peri-implant based on pocket depth and bony loss, early peri-implantitis occurs when pocket depth is more than 4 mm and bone loss is lower than 25%, moderate peri-implantitis establishes when pocket depth is more than 6 mm and bony loss is in-between 25% and 50%, and in addition to severe peri-implantitis manifests when pocket depth is more than 8 mm with bone loss is higher than 50% [6]. Multiple risk factors play an essential role in the development of peri-implantitis include past periodontal condition, improper plaque removal, smoking, residual cement, and occlusal overloading, genetic factor, improper surgical placement, poor oral hygiene, and diabetic condition [7],[8],[9],[10]. Porphyromonas gingivalis, Prevotella intermedia, and Aggregatibacter actinomycetemcomitans microbiotas are linked with biofilm formation on dental implants [11]. Bacterial infection-induced immune response to recruit neutrophils, macrophages, T cells, and B cells migrates into the implant-bone interface. Finally, loss of alveolar bone leads to instability and loss of the implant [12]. Different therapies present today, such as surgery, laser therapy, and innovative treatments such as cold atmospheric pressure air plasma jet (CAPAJ), enamel matrix derivative, and platelet rich fibrin (PRF) gel, are all used to treat peri-implantitis [13].

MATERIALS AND METHODS


Data sources: The PubMed/MEDLINE, SCOPUS, and Web of Science databases were used to conduct the literature search from June to September 2021.

Study selection: Non-surgical and surgical peri-implantitis treatment modalities are the main themes of this study.

RESULTS


Etiologies of peri-implantitis

Peri-implantitis appears to be multifactorial pathology, including the response of the patient’s host/microbe, implant properties, soft tissue and the hard condition around the implant, the experience of the dentist in surgical and prosthetic parts. As in general periodontal diseases, dental plaque formation is considered the main predisposing factor for the development of peri-implantitis [14]. Canullo et al. categorized the etiological factors of peri-implantitis concerning keywords of many systematic reviews into (individual susceptibility to peri-implant disease, plaque as etiological factors of peri-implantitis, biomechanics as trigger factor of peri-implantitis, surgical and prosthetic procedures as etiological factors of peri-implantitis) [15]. Smoking patients with IL-1 gene polymorphism might have a higher risk for peri-implant bone loss since a synergic effect is expected. In these reports, a clear association between heavy smokers with a positive IL-1 genotype and implant complications (loss of implant, or peri-implantitis) was found [16],[17]. As a result of the meta-analysis of Clementini et al., cigarette smoking raised the yearly rate of bone resorption to 0.16 mm/year [18] and minimized the amount of osseointegration, and endangered the oral hygiene surrounding dental implants [19]. Medical diseases like diabetes mellitus, immunosuppression disease play a significant effect in the establishment of peri-implantitis around the dental implant. Iatrogenic causes as cementitis, lack of keratinized gingiva at the area of implantation, history of failures of implants [20],[21]. The remaining teeth with periodontitis should be considered a possible infection source (edentulous vs partially edentulous, which promotes periodontal pathogen colonization of peri-implant tissues) [22].

 

Pathogenesis of peri-implantitis

Peri-implantitis is a condition that is both progressive and irreversible attacks soft and hard tissue surrounding the dental implant, furthermore, it invades by inflammatory cells, plasma cells, and B-lymphocytes with the absence of a protective tissue layer over the bone [2]. From a histological point of view, peri-implantitis when compared with periodontitis has two-fold large and extra blood vessels with invasion connective tissue than periodontitis [23]. In response to bacterial infection, the immune system recruits the neutrophils, macrophages, T cells, and B cells to the lesion [24]. Corrêa et al. identified the role of fibroblasts in the pathogenesis of peri-implantitis by upregulating both vascularity and matrix degradation [25]. Compared to periodontal tissues, peri-implant tissues are more prone to inflammatory illness due to decreased vascularization and parallel orientation of collagen fibers. This hypothesis is supported by immunohistochemical examination through increased formation of inflammatory infiltrate, vascular endothelial growth factor (VEGF), nitric oxide 1/3, leukocytes, Ki-67, and lymphocytes [26]. Also higher level of matrix metalloproteinase (MMP-8) shows an increase of up to 97% in peri-implantitis [27]. Papi et al. demonstrated the extracellular matrix antibodies are more abundant in peri-implantitis [28]. Rokaya et al. stated that the rapid disease progression rate in peri-implantitis causes a faster and more severe bone loss than the periodontal disease [2]. In peri-implantitis, the difference in microorganism in implant site, host defense mechanism, in addition to the absence of periodontal ligaments may induce a nonlinear bone destruction form that occurs over time in peri-implantitis [29].

 

Preventive strategies

Whatever the type of treatment used, the successful treatment strategy is highly dependent on the preventive measures taken by the patients, in addition to the early diagnoses and treatment planning. Appropriate and organized treatment planning inhibits the development of peri-implantitis. This is achieved by thorough individual assessment and eliminating of risk factors, establishing of healthy soft and hard tissue conditions with excellent implant design according to the available surgical area for implantation followed by atraumatic surgical procedure and periodic clinical examinations with periodontal probing status. One of the most important preventive strategies is the toothbrush for plaque removal, followed by stannous fluoride-sodium hexametaphosphate containing dentifrice and chlorhexidine containing mouthwash which has an important role in the elimination of gingivitis and plaque removal [30].

 

Peri-implantitis treatment

Generally, the treatment should be focused on infection and bacterial control as microbial biofilm plays a crucial role in disease progression. Lang et al. affirmed that the dental implant should only be removed completely when there is mobility and bone loss surpasses 60% [31]. Treatment modalities are including surgical and non-surgical treatment according to the rate of disease progression.

 

Non-surgical peri-implantitis treatment

Multiple non-surgical peri-implantitis therapies involve mechanical, chemical, antibiotic, antiseptic, laser, and photodynamic therapies.

 

Mechanical approaches

The main goal of mechanical treatment is eliminating microbial biofilm from the subgingival surface of the dental implant by leaving a smooth surface to avoid further plaque formation. This was reached by using plastic or metal curettes or ultrasonic scalers or piezoelectric scalers and air abrasive devices [30]. Toma et al. consider a combination between mechanical techniques and using of antibiotics or surgical methods in their study to achieve better consequences [32]. Moreover, another study supports surgical treatment with mechanical debridement, to increase the effectiveness of mechanical treatment [33]. Hence, the mechanical techniques alone are unsuccessful to eradicate bacterial contamination and the treatment should be coupled with other treatments as antiseptic with surgical procedure.

 

Chemical methods

It includes topical application of antibacterial agents. The most common chemical agents used to eliminate bacterial growth are citric acid, ethylenediaminetetraacetic acid (EDTA), hydrogen peroxide (HP), and saline. Citric acid is a chemotherapeutic agent with a high capacity of biofilm removing and decreasing contamination from the implant titanium surface, has a low toxic effect on osteoblasts cells in low concentration (4–10%) in contrast to high concentration 40% with (pH = 1) may be toxic to peri-implant tissue [34]. The most common agent chelating to eradicate the smear layer and decontaminate implant surface is EDTA. Its effect apparently on periodontal regeneration; however, it should be used with caution due to some cytotoxic effects [35]. The biofilm that formed on the implant surface can be diminished by 10% of hydrogen peroxide and also may decrease bacterial colonization up to 99.9%. Furthermore, swabbing the implant surface for 1 minute with HP can induce re-osseointegration in peri-implantitis lesions, on the other hand, due to its high reactivity, it can harm oral mucosa, so it should be used with caution [34]. Surgical decontamination of implant surfaces followed by the toilet with sterile saline with postsurgical antibiotic prescription prevents the advancement of peri-implantitis [36].

 

Antiseptic

Adequate implant adhesion with subsequent decreasing inflammatory reaction is achieved by topical application of chlorhexidine gluconate (CHX) as irrigant solution in concentration 0.12% [37]. Chlorhexidine inhibits bacterial colonization, hence, there is a reduction in clinical parameters [bleeding on probing (BOP), probing pocket depth (PPD)] with radiographical confirmation. Moreover, laboratory investigation showed a decrease in inflammatory signs at a high level [IL-1 beta, prostaglandin E2 (PGE-2), and VEGF] [36]. These findings came in the same line with the study of Rokaya et al., who found that the local application of CHX with controlled-release induces periodontal re-osseointegration. Chlorhexidine gluconate has certain drawbacks if used in concentration 2% which permanently jeopardizes cell migration and the survival of fibroblast, myoblast, and osteoblast [2].

 

Antibiotics drugs

Bacteriostatic (doxycycline, minocycline) or bactericidal (gentamicin, cefazolin) drugs can be used along with mechanical debridement for control of the infection [38],[39]. Different topical and systemic antibiotic applications have been studied in the treatment of peri-implantitis. Doxycycline and minocycline, when applied topically after local debridement of the lesion with continuous irrigation, appeared more effective in treating a moderate deep lesion. Host defense mechanisms and immunity can be enhanced by administering systemic antibiotics to eliminate infection through combating residual subgingival bacteria that stay after mechanical curettage [40]. Different sustained release devices like a chip, gel, polymeric fiber, and microcapsules have been innovative to act as a reservoir of a constant level of specific antibiotics at specific infection areas [30].

 

Photodynamic therapy

Photodynamic therapy is considered a supplementary therapy for peri-implantitis treatment. As it is a relatively new approach, it decreases bacterial colonization and promotes crestal bone remodeling after mechanical debridement. Regarding decontamination of implant surfaces and surrounding tissue, 200 μg/mL methylene blue under red laser has been used against aerobic and anaerobic bacteria such as A. actinomycetemcomitans, Enterococcus faecalis, P. gingivalis, Streptococcus mutans, P. intermedia [41]. Bacterial infection also can be subsided by utilizing various antimicrobial agents like bioactive glass (BAG), which possess high efficacy against infection and because of these characteristics, BAG may be the optimal bone substitute for curing peri-implant infections [42].

 

Laser therapy

Concerning of superior properties of laser in pain relief, patient comfort, and better result in terms of bleeding with bactericidal effect, various laser types utilized for treating the peri-implantitis are CO2, Er, Cr:YSGG-(erbium, chromium-doped: yttrium scandium-gallium-garnet) lasers and Diode-Er:YAG-(erbium-doped: yttrium-aluminum-garnet) [43]. When the laser is applied to the infected area around the dental implant, it improves the cellular photoreceptors activation (cytochrome C oxidase) to absorb the laser radiation and convey it to the cell’s mitochondria. The adenosine triphosphate of cells will increase, which is the main product of the Krebs cycle and cytochrome C oxidase, also laser causes an increase in cellular activity. Increased adenosine triphosphate activates macrophages, endothelial cells, fibroblasts, growth factors, nerve cells, mast cells, and bradykinin. As a result of this sequence, there is a reduction of plaque index [44] with an increase of collagen fiber synthesis, which is resulting in stimulating tissue regeneration around the dental implant [45].

 

Surgical peri-implantitis treatment

Regarding the presence of deep pockets ≥5 mm, with inferior changes in clinical parameters (BOP, PPD), the principal purpose of surgical approaches is to get direct access to peri-implant site subgingivally to get rid of granulation tissue and decontamination of the implant surface to enhance new attachment and a re-osseointegration is established. During the last five years, many literature reviews dealt with surgical treatment in form of resective therapy, regenerative therapy, implantoplasty, and air-abrasive powder [2],[30],[38]. Recently, a narrative review by Roccuzzo et al. categorized the surgical treatment in a different pattern [46]. Roccuzzo et al. reported in their systemic review that high survival rates with moderate composite success rates when estimating the result of open flap debridement without resection of the bony pocket of peri-implantitis with PPD ≤ 5 mm. They found that there is no bleeding or suppuration on probing and that no additional bone loss has occurred [47]. This systemic review is supported by the study of Heitz-Mayfield et al.; in which they evaluate the success rate of surgical treatment with mechanical debridement in conjunction with the delivery of systemic antibiotic (amoxicillin and metronidazole) without bone resection, they found there is a complete resolution of sign and symptoms of disease [48]. These results highlight the challenge faced by clinicians in keeping up with mid- to long-term, positive short-term results. Interestingly, recurrent peri-implantitis with an increased level of marginal bone loss in presence of PPD ≥ 6 mm and subsequent loss of the implant, this scenario could be treated with open flap debridement with bone recontouring as approved by Carcuac et al. in their five years’ study. Moreover, they reported the effect of modification of implants surfaces on the progression of the disease [49]. Concerning implantoplasty, the removal of supracrestal implant threads in presence of a bony defect is indicated to have a smooth implant surface and achieve a good surgical approach that prevents chronic peri-implantitis compared to bone resection alone or using glycine air abrasive [50],[51]. The drawback of implantoplasty and its inferior consequence such as fracture implant or precipitate titanium particles in the peri-implant soft tissue limited its use and need more clinical evidence to approve its usage [52]. Different reconstructive procedures utilizing barrier membranes, autogenous bone, and/or numerous bone substitutes are effective in peri-implantitis to affect re-osseointegration around dental implants [53],[54]. The result of a combination between resective surgery and reconstructive surgery using bone graft shows clinical improvements in periodontal pocket depth and clinical attachment level [55]. On contrary, the study of Roccuzzo et al. found that there is an increase in mucosal recession after one year of treatment about 2.5 mm that restricted their efficacy and limited usage in the posterior implant as an esthetic priority not significant [56]. The importance of keratinized mucosa after treatment of peri-implantitis is unclear [57]. Recently, four protocols have been reported to treat supracrestal or dehiscence bone defect with deficient of keratinized mucosa: (A) partial-thickness flap apically positioned, (B) bone recontouring to have a flat design, (C) implantoplasty to manage exposed surface implant, and finally (D) Stabilized free epithelial graft on vascular recipient bed [58]. Interestingly, the result of this protocol in the case series study demonstrated complete resolution of the diseased implant.

CONCLUSION


Implants have become a well-known therapy in dentistry for replacing lost teeth. This treatment option appears to be a “safe” treatment option when followed appropriately and anatomical and intra-individual limiting factors are taken into account. However, there is growing evidence that peri-implant inflammations exist, and they are the most common problems affecting both the soft and hard tissues around a dental implant, potentially leading to its loss. As microbial biofilm plays such an important role in disease progression, treatment should generally focus on infection and bacterial management.

Ethical approval


The authors disclosed that this work received institutional ethical approval (protocol number 3558 on 7/6/2021).

REFERENCES


1.

Albrektsson T, Canullo L, Cochran D, De Bruyn H. “Peri-implantitis”: A complication of a foreign body or a man-made “disease”. Facts and fiction. Clin Implant Dent Relat Res 2016;18(4):840–9. [CrossRef] [Pubmed]   Back to citation no. 1  

2.

Rokaya D, Srimaneepong V, Wisitrasameewon W, Humagain M, Thunyakitpisal P. Peri-implantitis Update: Risk indicators, diagnosis, and treatment. Eur J Dent 2020;14(4):672–82. [CrossRef] [Pubmed]   Back to citation no. 1  

3.

Mahato N, Wu X, Wang L. Management of peri-implantitis: A systematic review, 2010–2015. Springerplus 2016;5:105. [Pubmed]   Back to citation no. 1  

4.

Lee CT, Huang YW, Zhu L, Weltman R. Prevalences of peri-implantitis and peri-implant mucositis: Systematic review and meta-analysis. J Dent 2017;62:1–12. [CrossRef] [Pubmed]   Back to citation no. 1  

5.

McCrea SJJ. Advanced peri-implantitis cases with radical surgical treatment. J Periodontal Implant Sci 2014;44(1):39–47. [CrossRef] [Pubmed]   Back to citation no. 1  

6.

Froum SJ, Rosen PS. A proposed classification for peri-implantitis. Int J Periodontics Restorative Dent 2012;32(5):533–40. [Pubmed]   Back to citation no. 1  

7.

Froum SJ, Rosen PS. A proposed classification for peri-implantitis. Int J Periodontics Restorative Dent 2012;32(5):533–40. [CrossRef] [Pubmed]   Back to citation no. 1  

8.

Katafuchi M, Weinstein BF, Leroux BG, Chen YW, Daubert DM. Restoration contour is a risk indicator for peri-implantitis: A cross-sectional radiographic analysis. J Clin Periodontol 2018;45(2):225–32. [CrossRef] [Pubmed]   Back to citation no. 1  

9.

Monje A, Insua A, Wang HL. Understanding peri-implantitis as a plaque-associated and site-specific entity: on the local predisposing factors. J Clin Med 2019;8(2):279. [CrossRef] [Pubmed]   Back to citation no. 1  

10.

Yi Y, Koo KT, Schwarz F. Ben Amara H, Heo SJ. Association of prosthetic features and peri-implantitis: A cross-sectional study. J Clin Periodontol 2020;47(3):392–403. [CrossRef] [Pubmed]   Back to citation no. 1  

11.

Ata-Ali J, Candel-Marti ME, Flichy-Fernández AJ, Peñarrocha-Oltra D, Balaguer-Martinez JF, Peñarrocha Diago M. Peri-implantitis: Associated microbiota and treatment. Med Oral Patol Oral Cir Bucal 2011;16(7):e937–43. [CrossRef] [Pubmed]   Back to citation no. 1  

12.

Belibasakis GN. Microbiological and immunopathological aspects of peri-implant diseases. Arch Oral Biol 2014;59(1):66–72. [CrossRef] [Pubmed]   Back to citation no. 1  

13.

Vijay Ebenezer AR. Treatment modalities of peri-implantitis – a review. European Journal of Molecular & Clinical Medicine 2020;7(5):1574–5.   Back to citation no. 1  

14.

Berglundh T, Armitage G, Araujo MG, et al. Peri-implant diseases and conditions: Consensus report of workgroup 4 of the 2017 world workshop on the classification of periodontal and peri-implant diseases and conditions. J Clin Periodontol 2018;45 Suppl 20:S286–91. [CrossRef] [Pubmed]   Back to citation no. 1  

15.

Canullo L, Schlee M, Wagner W, Covani U; Montegrotto Group for the Study of Peri-implant Disease. International brainstorming meeting on etiologic and risk factors of peri-implantitis, Montegrotto (Padua, Italy), August 2014. Int J Oral Maxillofac Implants 2015;30(5):1093–104. [CrossRef] [Pubmed]   Back to citation no. 1  

16.

Feloutzis A, Lang NP, Tonetti MS, et al. IL-1 gene polymorphism and smoking as risk factors for periimplant bone loss in a well-maintained population. Clin Oral Implants Res 2003;14(1):10–7. [CrossRef] [Pubmed]   Back to citation no. 1  

17.

Gruica B, Wang HY, Lang N, Buser D. Impact of IL-1 genotype and smoking status on the prognosis of osseointegrated implants. Clin Oral Implants Res 2004;15(4):393–400. [CrossRef] [Pubmed]   Back to citation no. 1  

18.

Clementini M, Rossetti PHO, Penarrocha D, Micarelli C, Bonachela WC, Canullo L. Systemic risk factors for peri-implant bone loss: A systematic review and meta-analysis. Int J Oral Maxillofac Surg 2014;43(3):323–34. [CrossRef] [Pubmed]   Back to citation no. 1  

19.

Kasat V, Ladda R. Smoking and dental implants. J Int Soc Prev Community Dent 2012;2(2):38–41. [CrossRef] [Pubmed]   Back to citation no. 1  

20.

Charyeva O, Altynbekov K, Zhartybaev R, Sabdanaliev A. Long-term dental implant success and survival – a clinical study after an observation period up to 6 years. Swed Dent J 2012;36(1):1–6. [Pubmed]   Back to citation no. 1  

21.

Renvert S, Aghazadeh A, Hallström H, Persson GR. Factors related to peri-implantitis – a retrospective study. Clin Oral Implants Res 2014;25(4):522–9. [CrossRef] [Pubmed]   Back to citation no. 1  

22.

Brito C, Tenenbaum HC, Wong BKC, Schmitt C, Nogueira-Filho G. Is keratinized mucosa indispensable to maintain peri-implant health? A systematic review of the literature. J Biomed Mater Res B Appl Biomater 2014;102(3):643–50. [CrossRef] [Pubmed]   Back to citation no. 1  

23.

Carcuac O, Berglundh T. Composition of human peri-implantitis and periodontitis lesions. J Dent Res 2014;93(11):1083–8. [CrossRef] [Pubmed]   Back to citation no. 1  

24.

Belibasakis GN. Microbiological and immunopathological aspects of peri-implant diseases. Arch Oral Biol 2014;59(1):66–72. [CrossRef] [Pubmed]   Back to citation no. 1  

25.

Corrêa MG, Pimentel SP, Ribeiro FV, Cirano FR, Casati MZ. Host response and peri-implantitis. Braz Oral Res 2019;33(suppl 1):e066. [CrossRef] [Pubmed]   Back to citation no. 1  

26.

Degidi M, Artese L, Piattelli A, et al. Histological and immunohistochemical evaluation of the peri-implant soft tissues around machined and acid-etched titanium healing abutments: A prospective randomised study. Clin Oral Investig 2012;16(3):857–66. [CrossRef] [Pubmed]   Back to citation no. 1  

27.

Zhang L, Li X, Yan H, Huang L. Salivary matrix metalloproteinase (MMP)-8 as a biomarker for periodontitis: A PRISMA–compliant systematic review and meta-analysis. Medicine (Baltimore) 2018;97(3):e9642. [Pubmed]   Back to citation no. 1  

28.

Papi P, Di Carlo S, Rosella D, De Angelis F, Capogreco M, Pompa G. Peri-implantitis and extracellular matrix antibodies: A case-control study. Eur J Dent 2017;11(3):340–4. [CrossRef] [Pubmed]   Back to citation no. 1  

29.

Hasturk H, Kantarci A. Activation and resolution of periodontal inflammation and its systemic impact. Periodontol 2000 2015;69(1):255–73. [CrossRef] [Pubmed]   Back to citation no. 1  

30.

Vyas D, Deshpande N. Periodontal management of peri-implant diseases: A literature review. International Journal of Scientific Research 2017;6(3):92–4. [CrossRef]   Back to citation no. 1  

31.

Lang NP, Lindhe J. Clinical Periodontology and Implant Dentistry. 6ed. New York, USA: John Wiley & Sons; 2015. p. 505–16.   Back to citation no. 1  

32.

Toma S, Brecx MC, Lasserre JF. Clinical evaluation of three surgical modalities in the treatment of peri-implantitis: A randomized controlled clinical trial. J Clin Med 2019;8(7):966. [CrossRef] [Pubmed]   Back to citation no. 1  

33.

Hallström H, Persson GR, Lindgren S, Renvert S. Open flap debridement of peri-implantitis with or without adjunctive systemic antibiotics: A randomized clinical trial. J Clin Periodontol 2017;44(12):1285–93. [CrossRef] [Pubmed]   Back to citation no. 1  

34.

Ntrouka VI, Slot DE, Louropoulou A, Van der Weijden F. The effect of chemotherapeutic agents on contaminated titanium surfaces: A systematic review. Clin Oral Implants Res 2011;22(7):681–90. [CrossRef] [Pubmed]   Back to citation no. 1  

35.

Kotsakis GA, Lan C, Barbosa J, et al. Antimicrobial agents used in the treatment of peri-implantitis alter the physicochemistry and cytocompatibility of titanium surfaces. J Periodontol 2016;87(7):809–19. [CrossRef] [Pubmed]   Back to citation no. 1  

36.

Moslemi N, Shahnaz A, Bahador A, Torabi S, Jabbari S, Oskouei ZA. Effect of postoperative amoxicillin on early bacterial colonization of peri-implant sulcus: A randomized controlled clinical trial. J Dent (Tehran) 2016;13(5):309–17. [Pubmed]   Back to citation no. 1  

37.

Roccuzzo A, De Ry SP, Sculean A, Roccuzzo M, Salvi GE. Current approach for the non-surgical management of peri-implantitis disease. Curr Oral Health Rep 2020;7:274–82. [CrossRef]   Back to citation no. 1  

38.

Smeets R, Henningsen A, Jung O, Heiland M, Hammächer CH, Stein JM. Definition, etiology, prevention and treatment of peri-implantitis – a review. Head face med 2014;10:34. [CrossRef] [Pubmed]   Back to citation no. 1  

39.

Cha JK, Lee JS, Kim CS. Surgical therapy of peri-implantitis with local minocycline: A 6-month randomized controlled clinical trial. J Dent Res 2019;98(3):288–95. [CrossRef] [Pubmed]   Back to citation no. 1  

40.

Rokaya D, Srimaneepong V, Sapkota J, Qin J, Siraleartmukul K, Siriwongrungson V. Polymeric materials and films in dentistry: An overview. J Adv Res 2018;14:25–34. [CrossRef] [Pubmed]   Back to citation no. 1  

41.

Garcia de Carvalho G, Sanchez-Puetate JC, Casalle N, Marcantonio E Jr, Leal Zandim-Barcelos D. Antimicrobial photodynamic therapy associated with bone regeneration for peri-implantitis treatment: A case report. Photodiagnosis Photodyn Ther 2020;30:101705. [CrossRef] [Pubmed]   Back to citation no. 1  

42.

Skallevold HE, Rokaya D, Khurshid Z, Zafar MS. Bioactive glass applications in dentistry. Int J Mol Sci 2019;20(23):5960. [CrossRef] [Pubmed]   Back to citation no. 1  

43.

Clem D, Gunsolley JC. Peri-implantitis treatment using Er:YAG laser and bone grafting. A prospective consecutive case series evaluation: 1 year posttherapy. Int J Periodontics Restorative Dent 2019;39(4):479–89. [CrossRef] [Pubmed]   Back to citation no. 1  

44.

Lin GH, Suárez López Del Amo F, Wang HL. Laser therapy for treatment of peri-implant mucositis and peri-implantitis: An American Academy of Periodontology best evidence review. J Periodontol 2018;89(7):766–82. [CrossRef] [Pubmed]   Back to citation no. 1  

45.

Mehdiyev I, Gülsen U, Sentürk MF, Sayan NB. Radiographic evaluation of low-level laser therapy-enhanced maxillary sinus augmentation with simultaneous dental implant placement. Ann Maxillofac Surg 2019;9(1):48–52. [CrossRef] [Pubmed]   Back to citation no. 1  

46.

Roccuzzo A, Stähli A, Monje A, Sculean A, Salvi GE. Peri-implantitis: A clinical update on prevalence and surgical treatment outcomes. J Clin Med 2021;10(5):1107. [CrossRef] [Pubmed]   Back to citation no. 1  

47.

Roccuzzo M. Layton DM. Roccuzzo A. Heitz-Mayfield LJ. Clinical outcomes of peri-implantitis treatment and supportive care: A systematic review. Clin Oral Implant Res 2018;29 Suppl 16:331–50. [CrossRef] [Pubmed]   Back to citation no. 1  

48.

Heitz-Mayfield LJA, Salvi GE, Mombelli A, et al. Supportive peri-implant therapy following anti-infective surgical peri-implantitis treatment: 5-year survival and success. Clin Oral Implant Res 2018:29(1):1–6. [CrossRef] [Pubmed]   Back to citation no. 1  

49.

Carcuac O, Derks J, Abrahamsson I, Wennström, JL, Berglundh T. Risk for recurrence of disease following surgical therapy of peri-implantitis-A prospective longitudinal study. Clin Oral Implant Res 2020;31(1):1072–7. [CrossRef] [Pubmed]   Back to citation no. 1  

50.

Bianchini MA, Galarraga-Vinueza ME, Apaza-Bedoya K, De Souza JM, Magini R, Schwarz F. Two to six-year disease resolution and marginal bone stability rates of a modified resective-implantoplasty therapy in 32 peri-implantitis cases. Clin Implant Dent Relat Res 2019;21(4):758–65. [CrossRef] [Pubmed]   Back to citation no. 1  

51.

Lasserre JF, Brecx MC, Toma S. Implantoplasty versus glycine air abrasion for the surgical treatment of peri-implantitis: A randomized clinical trial. Int J Oral Maxillofac Implant 2020;35(35):197–206. [CrossRef] [Pubmed]   Back to citation no. 1  

52.

Stavropoulos A, Bertl K, Eren S, Gotfredsen K. Mechanical and biological complications after implantoplasty—A systematic review. Clin Oral Implants Res 2019;30(9):833–48. [CrossRef] [Pubmed]   Back to citation no. 1  

53.

Roccuzzo M, Gaudioso L, Lungo M, Dalmasso P. Surgical therapy of single peri-implantitis intrabony defects, by means of deproteinized bovine bone mineral with 10% collagen. J Clin Periodontol 2016;43(3):311–8. [CrossRef] [Pubmed]   Back to citation no. 1  

54.

Renvert S, Roos-Jansåker AM, Persson GR. Surgical treatment of peri-implantitis lesions with or without the use of a bone substitute—a randomized clinical trial. J Clin Periodontol 2018;45(10):1266–74. [CrossRef] [Pubmed]   Back to citation no. 1  

55.

Monje A, Pons R, Roccuzzo A, Salvi GE, Nart J. Reconstructive therapy for the management of periimplantitis via submerged guided bone regeneration: A prospective case series. Clin Implant Dent Relat Res 2020;22(3):342–50. [CrossRef] [Pubmed]   Back to citation no. 1  

56.

Roccuzzo M, Dalmasso P, Pittoni D, Roccuzzo A. Treatment of buccal soft tissue dehiscence around single implant: 5-year results from a prospective study. Clin Oral Investig 2019;23(4):1977–83. [CrossRef] [Pubmed]   Back to citation no. 1  

57.

Ravidà A, Saleh I, Siqueira R, et al. Influence of keratinized mucosa on the surgical therapeutical outcomes of peri-implantitis. J Clin Periodontol 2020;47(4):529–39. [CrossRef] [Pubmed]   Back to citation no. 1  

58.

Monje, A, Blasi G, Nart J, Urban IA, Nevins M, Wang HL. Soft tissue conditioning for the surgical therapy of peri-implantitis: A prospective 12-month study. Int J Periodont Restor Dent 2020;40(6):899–906. [CrossRef] [Pubmed]   Back to citation no. 1  

SUPPORTING INFORMATION


Acknowledgments

We would like to thank the Department of Oral and Maxillofacial Surgery, College of Dentistry, the University of Mosul for their support to conduct this work.

Author Contributions

Alyaa I Naser - Conception of the work, Design of the work, Acquisition of data, Drafting the work, Revising the work critically for important intellectual content, Final approval of the version to be published, Agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Rayan S Hamed - Conception of the work, Design of the work, Acquisition of data, Drafting the work, Revising the work critically for important intellectual content, Final approval of the version to be published, Agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Guaranter of Submission

The corresponding author is the guarantor of submission.

Source of Support

None

Consent Statement

Written informed consent was obtained from the patient for publication of this article.

Data Availability

All relevant data are within the paper and its Supporting Information files.

Conflict of Interest

Authors declare no conflict of interest.

Copyright

© 2021 Alyaa I Naser et al. This article is distributed under the terms of Creative Commons Attribution License which permits unrestricted use, distribution and reproduction in any medium provided the original author(s) and original publisher are properly credited. Please see the copyright policy on the journal website for more information.